Comparable stake leader
Catalyst4, Inc.
SEC ownership of MapLight Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001770069.
Disclosed value leader
Catalyst4, Inc.
Comparable rows
50/50
Latest evidence
14 Aug 2026
- Public ticker
- MPLT on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Catalyst4, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Catalyst4, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
14 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001770069
- Issuer location
- Redwood City, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of MapLight Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Catalyst4, Inc.
Disclosed value leader
Catalyst4, Inc.
Comparable rows
50/50
Latest evidence
14 Aug 2026
13D/G
3/4/5
13F
Lead comparable stake: 50%
13D/G row: Catalyst4, Inc.
Showing 1-8 of 50 holder rows.
Quick read
Catalyst4, Inc. leads the comparable SEC ownership view at 50%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Catalyst4, Inc.'s linked filing trail.
Comparable ownership
Top 5
Catalyst4, Inc.
50%
T. Rowe Price Investment Manageme...
7.4%
Forbion Growth Opportunities Fund...
7.1%
Pivotal bioVenture Partners Fund ...
5.5%
Novo Holdings A/S
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Catalyst4, Inc. |
13D/G
3/4/5
10%+ Owner
|
50%
|
$386,330,234
27,536,011 shares
|
+$93,009,388 | 14 Aug 2026 |
| T. Rowe Price Investment Management, Inc. |
13F
13D/G
Company
|
7.4%
from 13D/G
|
$99,698,000
2,781,728 shares
|
— | 30 Jun 2026 |
| Forbion Growth Opportunities Fund III Cooperatief U.A. |
13D/G
|
7.1%
|
$61,527,448
3,226,400 shares
|
$0 | 31 Dec 2025 |
| Pivotal bioVenture Partners Fund II, L.P. |
13D/G
Nan Fung Group Holdings Limited
|
5.5%
|
$40,909,712
2,915,874 shares
|
$0 | 13 Aug 2026 |
| Novo Holdings A/S |
13F
13D/G
3/4/5
Company · 10%+ Owner
|
4.9%
from 13D/G
|
$132,128,532
3,686,622 shares
|
— | 30 Jun 2026 |
| FCPM III SERVICES B.V. |
13F
Company
|
6.1%
|
$115,634,176
3,226,400 shares
|
— | 30 Jun 2026 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
3.7%
|
$69,827,502
1,948,312 shares
|
— | 30 Jun 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
2.7%
|
$50,999,000
1,422,935 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$70,574,368.
Buys
$99,557,496
Insiders: 4
Sells
$28,983,128
Insiders: 8
Net
+$70,574,368
Shares: +7,622,887
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 8,592,655
Shares: 969,768
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 8,553,531 | 324,917 | $98,863,650 | $11,455,188 | +$87,408,462 |
| 3-6 | 0 | 570,239 | $0 | $16,159,863 | -$16,159,863 |
| 6-9 | 39,124 | 74,612 | $693,846 | $1,368,077 | -$674,231 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to MapLight Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
Catalyst4, Inc.
Net 12M change
+$70,574,368
Latest report
17 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Catalyst4, Inc. | 10%+ Owner | $321,318,273 | +$98,714,948 | +44% | Filing P/S | 14 Aug 2026 |
| Christopher A. Kroeger | Chief Executive Officer, Director | $49,129,113 | -$12,541,737 | -20% | Median | 17 Aug 2026 |
| Erin Pennock Foff | Chief Medical Officer | $11,191,434 | -$3,375,583 | -23% | Median | 17 Aug 2026 |
| Vishwas Setia | Chief Financial Officer | $10,356,361 | -$1,103,291 | -9.6% | Filing P/S | 04 May 2026 |
| Robert C. Malenka | Director | $9,156,931 | -$1,599,229 | -15% | Mixed | 15 Apr 2026 |
| James Woodruff Lillie | Chief Scientific Officer | $7,530,342 | -$2,561,760 | -25% | Median | 17 Aug 2026 |
| Anatol Kreitzer | Chief Discovery Officer | $6,484,387 | -$2,781,199 | -30% | Median | 17 Aug 2026 |
| Kristopher Hanson | General Counsel | $5,503,339 | -$1,464,444 | -21% | Median | 17 Aug 2026 |
| Jonathan Gillis | CAO and Interim CFO | $5,464,954 | -$3,555,885 | -39% | Median | 17 Aug 2026 |
| Timothy John Garnett | Director | $1,373,920 | +$252,678 | +23% | Mixed | 23 Jun 2026 |
| Maria C. Walker | Director | $1,274,751 | Mixed | 23 Jun 2026 | ||
| George Pavlov | Director | $588,187 | +$441,168 | +300% | Mixed | 23 Jun 2026 |
| Troy Cox | Director | $430,547 | +$148,702 | +53% | Mixed | 28 Jul 2026 |
| Martin Babler | Director | $159,875 | Mixed | 23 Jun 2026 | ||
| Nanna Liebach Luneborg | Director | $79,937 | Mixed | 23 Jun 2026 | ||
| James D. Trenkle | Director | Mixed | 25 Oct 2025 | |||
| Novo Holdings A/S | 10%+ Owner | Mixed | 28 Oct 2025 |
Recent insider transactions for MapLight Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Anatol Kreitzer | MPLT | Voting Common Stock | Award | 3.44% | 6,020 | 180,926 | 17 Aug 2026 | Direct | ||
| Anatol Kreitzer | MPLT | Employee Stock Option (right to buy) | Award | 24,455 | 24,455 | 17 Aug 2026 | Direct | |||
| Jonathan Gillis | MPLT | Voting Common Stock | Award | 5.71% | 8,242 | 152,482 | 17 Aug 2026 | Direct | ||
| Jonathan Gillis | MPLT | Employee Stock Option (Right to Buy) | Award | 27,268 | 24,455 | 17 Aug 2026 | Direct | |||
| James Woodruff Lillie | MPLT | Voting Common Stock | Award | 3.82% | 7,730 | 210,110 | 17 Aug 2026 | Direct | ||
| James Woodruff Lillie | MPLT | Employee Stock Option (right to buy) | Award | 31,395 | 31,395 | 17 Aug 2026 | Direct | |||
| Kristopher Hanson | MPLT | Voting Common Stock | Award | 5.3% | 7,730 | 153,553 | 17 Aug 2026 | Direct | ||
| Kristopher Hanson | MPLT | Employee Stock Option (right to buy) | Award | 31,395 | 31,395 | 17 Aug 2026 | Direct | |||
| Erin Pennock Foff | MPLT | Voting Common Stock | Award | 4.47% | 13,360 | 312,261 | 17 Aug 2026 | Direct | ||
| Erin Pennock Foff | MPLT | Employee Stock Option (right to buy) | Award | 54,240 | 54,240 | 17 Aug 2026 | Direct | |||
| Christopher A. Kroeger | MPLT | Voting Common Stock | Award | 1.86% | 23,145 | 1,269,600 | 17 Aug 2026 | Direct | ||
| Christopher A. Kroeger | MPLT | Employee Stock Option (right to buy) | Award | 93,955 | 93,955 | 17 Aug 2026 | Direct | |||
| Catalyst4, Inc. | MPLT | Voting Common Stock | Purchase | 21% | $50,072,000 | $11.38 | 4,400,000 | 25,306,689 | 14 Aug 2026 | See footnote |
| Catalyst4, Inc. | MPLT | Warrants (right to buy) | Purchase | $33,328,154 | $11.38 | 2,928,686 | 2,928,686 | 14 Aug 2026 | See footnote | |
| James Woodruff Lillie | MPLT | Voting Common Stock | Sale | -9.84% | $276,908 | $12.54 | -22,082 | 202,380 | 03 Aug 2026 | Direct |
| Catalyst4, Inc. | MPLT | Voting Common Stock | Purchase | 5.02% | $13,000,000 | $13.00 | 1,000,000 | 20,906,689 | 30 Jul 2026 | See footnote |
| Catalyst4, Inc. | MPLT | Voting Common Stock | Purchase | 0.02% | $37,890 | $12.63 | 3,000 | 19,906,689 | 29 Jul 2026 | See footnote |
| Catalyst4, Inc. | MPLT | Voting Common Stock | Purchase | 1.05% | $2,276,904 | $11.04 | 206,225 | 19,903,689 | 28 Jul 2026 | See footnote |
| Troy Cox | MPLT | Voting Common Stock | Purchase | $148,702 | $9.52 | 15,620 | 15,620 | 28 Jul 2026 | By trust | |
| Jonathan Gillis | MPLT | Voting Common Stock | Sale | -11.4% | $694,463 | $37.60 | -18,469 | 144,240 | 17 Jul 2026 | Direct |
| Anatol Kreitzer | MPLT | Voting Common Stock | Sale | -8.94% | $645,719 | $37.60 | -17,173 | 174,906 | 17 Jul 2026 | Direct |
| Christopher A. Kroeger | MPLT | Voting Common Stock | Sale | -1.33% | $635,924 | $37.90 | -16,779 | 1,246,455 | 17 Jul 2026 | Direct |
| James Woodruff Lillie | MPLT | Voting Common Stock | Sale | -0.92% | $78,718 | $37.90 | -2,077 | 224,462 | 17 Jul 2026 | Direct |
| Kristopher L. Hanson | MPLT | Voting Common Stock | Sale | -0.77% | $42,827 | $37.90 | -1,130 | 145,823 | 17 Jul 2026 | Direct |
| Erin Pennock Foff | MPLT | Voting Common Stock | Sale | -1.21% | $138,562 | $37.90 | -3,656 | 298,901 | 17 Jul 2026 | Direct |
| Jonathan Gillis | MPLT | Voting Common Stock | Sale | -4.94% | $311,112 | $36.80 | -8,455 | 162,709 | 16 Jul 2026 | Direct |
| Anatol Kreitzer | MPLT | Voting Common Stock | Sale | -4.5% | $333,235 | $36.80 | -9,056 | 192,079 | 16 Jul 2026 | Direct |
| Christopher A. Kroeger | MPLT | Voting Common Stock | Sale | -5.19% | $2,541,341 | $36.79 | -69,082 | 1,263,234 | 16 Jul 2026 | Direct |
| James Woodruff Lillie | MPLT | Voting Common Stock | Sale | -3.64% | $314,412 | $36.79 | -8,547 | 226,539 | 16 Jul 2026 | Direct |
| Kristopher L. Hanson | MPLT | Voting Common Stock | Sale | -5.24% | $298,616 | $36.78 | -8,118 | 146,953 | 16 Jul 2026 | Direct |
| Erin Pennock Foff | MPLT | Voting Common Stock | Sale | -4.74% | $553,334 | $36.77 | -15,047 | 302,557 | 16 Jul 2026 | Direct |
| Jonathan Gillis | MPLT | Voting Common Stock | Sale | -5.55% | $367,093 | $36.51 | -10,055 | 171,164 | 15 Jul 2026 | Direct |
| Anatol Kreitzer | MPLT | Voting Common Stock | Sale | -4.76% | $366,940 | $36.49 | -10,055 | 201,135 | 15 Jul 2026 | Direct |
| Christopher A. Kroeger | MPLT | Voting Common Stock | Sale | -4.43% | $2,266,457 | $36.69 | -61,778 | 1,332,316 | 15 Jul 2026 | Direct |
| James Woodruff Lillie | MPLT | Voting Common Stock | Sale | -3.15% | $280,506 | $36.70 | -7,643 | 235,086 | 15 Jul 2026 | Direct |
| Kristopher L. Hanson | MPLT | Voting Common Stock | Sale | -4.47% | $266,427 | $36.70 | -7,260 | 155,071 | 15 Jul 2026 | Direct |
| Erin Pennock Foff | MPLT | Voting Common Stock | Sale | -8.22% | $1,042,594 | $36.64 | -28,455 | 317,604 | 15 Jul 2026 | Direct |
| Troy Cox | MPLT | Voting Common Stock | Award | 7,864 | 7,864 | 23 Jun 2026 | Direct | |||
| Troy Cox | MPLT | Stock Option (right to buy) | Award | 29,804 | 29,804 | 23 Jun 2026 | Direct | |||
| Martin Babler | MPLT | Voting Common Stock | Award | 7,864 | 7,864 | 23 Jun 2026 | Direct | |||
| Martin Babler | MPLT | Stock Option (right to buy) | Award | 29,804 | 29,804 | 23 Jun 2026 | Direct | |||
| Timothy John Garnett | MPLT | Voting Common Stock | Award | 7.94% | 3,932 | 53,457 | 23 Jun 2026 | Direct | ||
| Timothy John Garnett | MPLT | Stock Option (right to buy) | Award | 14,902 | 14,902 | 23 Jun 2026 | Direct | |||
| Nanna Liebach Luneborg | MPLT | Voting Common Stock | Award | 3,932 | 3,932 | 23 Jun 2026 | Direct | |||
| Nanna Liebach Luneborg | MPLT | Stock Option (right to buy) | Award | 14,902 | 14,902 | 23 Jun 2026 | Direct | |||
| George Pavlov | MPLT | Voting Common Stock | Award | 15.7% | 3,932 | 28,932 | 23 Jun 2026 | Direct | ||
| George Pavlov | MPLT | Stock Option (right to buy) | Award | 14,902 | 14,902 | 23 Jun 2026 | Direct | |||
| Maria C. Walker | MPLT | Voting Common Stock | Award | 6.69% | 3,932 | 62,703 | 23 Jun 2026 | Direct | ||
| Maria C. Walker | MPLT | Stock Option (right to buy) | Award | 14,902 | 14,902 | 23 Jun 2026 | Direct | |||
| Christopher A. Kroeger | MPLT | Voting Common Stock | Sale | -7.82% | $3,215,000 | $27.19 | -118,235 | 1,394,094 | 18 May 2026 | Direct |
* marks a reported price that did not pass the local price check.